[1]
2026. Assessment of Serum Levels of CA19-9 and Amylin in Relation to Glycemic Control in Type-2 Diabetic Patients. Al-Iraqia Medical College Journal. 3, 2 (Aug. 2026), 142–156. DOI:https://doi.org/10.58564/AIMCJ3.2.2026.322.